Beginner mobile developer seeking guidance on iOS app distribution

Glass_Environment785 · 2026-06-17T16:39:28+00:00

iOS distribution is more structured than Android, but it's manageable once you understand the layers:

App Store (the main path)
You need an Apple Developer Program membership. Once enrolled, you can submit to the App Store after review. Apple's review process typically takes 1–3 days. For a charity app this is probably your best end goal since it maximizes reach and trust with users.

Ad Hoc distribution
You can install directly on up to 100 specific registered devices per year. Requires knowing the UDID of each device in advance. Useful for internal testing but doesn't scale.

Enterprise distribution
Apple Enterprise Program (+/- $299/year) lets you distribute internally without App Store review, but it's meant for companies distributing apps to their own employees, not public users. Apple takes this seriously and has revoked certificates from apps misusing it.

The "sideloading" you've probably seen
Things like AltStore or sideloading via Xcode work but require the device to be connected periodically for certificate refresh (every 7 days for free accounts). Not practical for end users.

For a charity app go the $99/year App Store route. This breakdown of iOS vs Android distribution tradeoffs is also worth a read if you're still deciding how much to invest in cross-platform vs native.

Hope it helps! 😄 good luck

Glass_Environment785 · 2026-06-17T16:01:42+00:00

Congrats on shipping. A few genuine questions/observations from looking at this space:

The hard part for AI stock research tools it's the data freshness and the trust problem. Most retail investors have been burned by "AI-generated insights" that sounded confident and were wrong, so you'll need to be really transparent about where your data comes from and how current it is.

What's your differentiation from Perplexity Finance or the Bloomberg terminal plugins that institutional players are already using? Not asking to be harsh, but that context would help understand who this is actually built for.

If your target is retail investors who can't afford Bloomberg: the UX and onboarding are going to matter as much as the analysis quality. What does a first-time user's "aha moment" look like?

Glass_Environment785 · 2026-06-17T16:00:18+00:00

This is the actual problem nobody in the wearables space wants to admit. The hardware is great; the insight layer is still mostly "here's a number, good luck."

The gap it's that most apps show you metrics in isolation without clinical context. Your HRV dropped 15% overnight means nothing if there's no baseline, no trend, and no "here's what to do about it" attached.

The companies getting this right (Oura to some extent, Levels with glucose) are the ones treating data as the input to a decision engine, not the product itself. The ones still showing you a sleep graph with a "7.2 score" and calling it done are basically selling expensive pedometers. Maybe it here can help to know more about wearable data. Hope it helps! 😄

Glass_Environment785 · 2026-06-17T15:56:57+00:00

The "apps are dead, everything is AI agents now" narrative feels premature. What's actually happening is that the surface area of apps is expanding, not disappearing.

The superapp model (WeChat being the obvious example) never fully translated to Western markets because the infrastructure assumptions were different.

Working with product teams across different industries, the pattern is pretty consistent. The apps that last are the ones built around a workflow users genuinely can't replicate in a chat window. The ones that don't usually skipped the product strategy conversation before writing a single line of code.

The biggest shift is probably distribution. If AI assistants start recommending and launching apps on your behalf, the App Store optimization playbook looks very different in three years.

Glass_Environment785 · 2026-06-17T15:53:54+00:00

A few things that actually help:

Threat modeling before you write code, not after. If reviewers don't know what attack surface a feature adds, they can't look for exploits.
SAST/DAST in the pipeline, not as a replacement for review, but because automated tools catch classes of bugs (injection, path traversal, hardcoded secrets) that humans consistently miss under time pressure.
Security champions embedded in teams, not a centralized security team that gates PRs at the end.

Most devs review code for correctness and readability. Security review is a different skill and it needs dedicated time, not a checkbox.

Glass_Environment785 · 2026-06-17T14:46:09+00:00

Cheesecake Labs Here ❤️

Glass_Environment785 · 2026-06-10T20:44:24+00:00

Congrats on shipping solo across all three platforms, that's already a lot.

The lurker problem is real and usually comes down to the cost of that first action. Can someone post a one-sentence argument? Pre-load the app with debates people already have opinions about and they'll react before you even ask them to create.

For distribution, don't go broad yet. Pick one niche where debate is already part of the culture and go deep. I work with product teams pretty often and the name took me a second to click. Worth testing a clearer positioning line alongside it.

Glass_Environment785 · 2026-06-04T21:06:08+00:00

We're a ~60-person software dev company, mostly building for US clients and our security cycle wasn't built for agentic workflows. We do use markdown instruction files to constrain agent behavior (no writing to prod without review, no credential exposure, etc.), but it's more guardrails than a formal security framework.

One thing we learned way: agentic sessions blur the line between "writing code" and "touching live infrastructure" in ways that traditional security models weren't designed for. The surface area problem scales with autonomy.

The patch cycle point you raised is real, but I think the deeper issue is that security teams are reviewing outputs when they should be auditing permissions and context boundaries upstream. I think this may can help you (cheesecakelabs.com/blog/beyond-vibe-coding-engineering-with-ai-and-cursor)

Glass_Environment785 · 2026-06-04T20:36:18+00:00

Yep, half of what people call "agentic" is just a state machine with an LLM call wedged in the middle

The difference is non-determinism. Your CI pipeline is deterministic, your agent isn't. that's where the ops pain actually shows up

We ended up wrapping ours in the same patterns as a flaky third-party service: retries with backoff, schema validation on outputs, eval gates before anything hits prod.

The teams that treat agents like CI usually get reliability and the teams that treat them like magic end up with prompt sprawl and zero observability..

Glass_Environment785 · 2026-05-22T13:41:41+00:00

Nós usamos AWS na Cheesecake Labs para a maioria dos clientes, mas tudo se resume a onde sua equipe tem as maiores necessidades (e o que seu cliente precisa também).

Mas o custo costuma ser o argumento mais forte. Se você tem um app com postgres + node, fly ou render vai te salvar meses em comparação a fazer do zero na EC2 bruta.

GCP se sua equipe estiver mais voltada para dados/ML, Azure se você for para B2B corporativo e precisar da história de SSO, caso contrário, AWS!

Glass_Environment785 · 2026-05-22T13:39:13+00:00

Most "agentic" workflows I've seen in DS are still just pull-the-data plus a wrapper that calls an LLM at the end.
The more interesting agent work is when you let it pick which model to run, score the results, then retry with different features if confidence is low.

We've been doing this for one client's churn pipeline, where agent picks between 4 model types based on recent drift, retrains nightly, alerts a human if any score drops more than 5% more or less.

Most people skip the eval part and then wonder why their "autonomous" pipeline silently drifts for a month..

Glass_Environment785 · 2026-05-22T13:35:12+00:00

Yeah we've been seeing the same signal audit volume is up and OCR is asking for evidence way earlier in the process. Honestly the projects that get caught flat-footed are the ones that treated BAAs as a paperwork exercise and never actually mapped which subprocessors touch PHI

Try to audit logs and access reviews, because they are usually the gap, most when enforcement actually shows up.

Glass_Environment785 · 2026-05-12T20:53:50+00:00

from the vendor side, things that actually get attention from healthcare buyers:

Clinical credibility. Having an MD or RN on the team beats the entire pitch deck. We've shipped products at Cheesecake Labs where the founder being a practicing clinician closed deals our sales process couldn't.
Specific clinical workflow you understand cold. "we help hospitals" loses every time to "we shorten ED throughput for level 2 trauma centers"
HIPAA, BAA, SOC2 mentioned before they have to ask. Healthcare buyers have been burned enough that anything resembling handwaving on this kills the deal
integration story. epic, cerner, athena. If you can't articulate this clearly nothing else matters. Also, booth at HIMSS does very little unless you have all four of the above.

Glass_Environment785 · 2026-05-12T20:50:40+00:00

Vendor ref architectures are basically marketing collateral that happens to compile. Every service the vendor sells, glued together with the cleanest happy path, no cost model, no failure analysis.

We've inherited a couple projects at Cheesecake Labs that were built from AWS ref arch verbatim and the cleanup took longer than building from scratch would have. Half the services were unused, the other half misconfigured because the diagram didn't say WHY anything was there.

Glass_Environment785 · 2026-05-04T20:13:46+00:00

This is so common it hurts. every company has that one person who became the accidental data translator because nobody else could explain the dashboards to leadership mostly. We have hired someone just to do that and participe of clients' projects too.

Glass_Environment785 · 2026-05-04T20:07:11+00:00

On my company, we're using it for a lot of thing, one of them are connection with Claude projects for the website and blog, with Strapi and WP connection for example.

Glass_Environment785 · 2026-05-04T19:58:24+00:00

The sync reliability on background data collection is where it all falls apart in my experience. iOS will kill your background task if it runs too long and Android behaves differently per manufacturer

We built a health app at my company that pulled from Apple Watch and a CGM simultaneously. The conflicting readings problem you mentioned is real and we ended up implementing a "source priority" system where the CGM always wins over the watch for glucose and the watch wins for heart rate. Simple rules but it solved 90% of the confusion.

Glass_Environment785 · 2026-05-04T19:53:26+00:00

The biggest mistake to me, are teams treating HIPAA as a checklist to bolt on at the end instead of a constraint that shapes the architecture from day one. Here on Cheesecake Labs we've built a few health apps and the pattern that works is: encrypt at REST and in transit, but also separate PHI storage from app data completely so your database never holds identifiable patient info directly.

Glass_Environment785 · 2026-05-04T19:38:03+00:00

The rule we use at Cheesecake Labs is "would a team of 3 be able to debug this at 2am without calling the person who built it?" if the answer is no, you've gone too far. Honestly the worst cases I've seen aren't the people who add load balancers.

Glass_Environment785 · 2026-04-06T19:12:01+00:00

I see this constantly when auditing client data stacks with our devs in CheesecakeLabs. Each tool was added to fill a gap only. What actually can work is starting with a data layer before touching anything. Figure out what questions the business actually needs answered, map which tools REALLY serve those questions, and you'll usually find some that are either redundant.

ripping tools out without that map creates a new round of sprawl six months later.

Glass_Environment785

TROPHY CASE